• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CompuMed claims digital advance

Article

Bone densitometry firm CompuMed announced last week that it has successfully acquired images using both dual-energy x-ray absorptiometry and amorphous silicon x-ray detectors. The Manhattan Beach, CA, firm believes that being able to acquire such images

Bone densitometry firm CompuMed announced last week that it has successfully acquired images using both dual-energy x-ray absorptiometry and amorphous silicon x-ray detectors. The Manhattan Beach, CA, firm believes that being able to acquire such images will help the company in its development of Digital OsteoView 2000, a device designed to detect both osteoporosis and arthritis.

CompuMed scientists working with researchers at the University of Massachusetts used amorphous silicon flat-panel detectors licensed from Varian Associates, with whom CompuMed has an OEM agreement (SCAN 1/8/97). CompuMed plans to file for 510(k) clearance for Digital OsteoView 2000 later this year.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.